A first description of the Colombian national registry for rare diseases

BMC Research Notes

Volumn 10, Issue 1, 2017, Pages

  Mateus, Heidi Eliana ^a   Pérez, Ana María ^a   Mesa, Martha Lucía ^b   Escobar, Germán ^b   Gálvez, Jubby Marcela ^a   Montaño, José Ivo ^b   Ospina, Martha Lucía ^c   Laissue, Paul ^a  

^a UNIVERSIDAD DEL ROSARIO   (Colombia)

^b Programa Nacional de Prevención y Control de la Tuberculosis   (Colombia)

^c INSTITUTO NACIONAL DE SALUD   (Colombia)

Author keywords

Colombian health system; Orphan disease; Rare disease registry

Indexed keywords

ADOLESCENT; ADULT; AGED; CHILD; COLOMBIA; FEMALE; HUMAN; INFANT; MALE; MIDDLE AGED; NEWBORN; PRESCHOOL CHILD; RARE DISEASE; REGISTER; STATISTICS AND NUMERICAL DATA; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; COLOMBIA; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; RARE DISEASES; REGISTRIES; YOUNG ADULT;

EID: 85032337213     PISSN: None     EISSN: 17560500     Source Type: Journal    
DOI: 10.1186/s13104-017-2840-1     Document Type: Article

References (24)

1. Schieppati A, Henter J-I, Daina E, Aperia A. Why rare diseases are an important medical and social issue. Lancet (London, England). 2008;371:2039-41.
2. Rubinstein YR, Groft SC, Bartek R, Brown K, Christensen RA, Collier E, et al. Creating a global rare disease patient registry linked to a rare diseases biorepository database: Rare Disease-HUB (RD-HUB). Contemp Clin Trials. 2010;31:394-404.
3. Taruscio D, Capozzoli F, Frank C. Rare diseases and orphan drugs. Ann dell'Istituto Super di sanità. 2011;47:83-93.
4. Kodra Y, Fantini B, Taruscio D. Classification and codification of rare diseases. J Clin Epidemiol. 2012;65:1026-7.
5. Montserrat Moliner A, Waligóra J. The European Union policy in the field of rare diseases. Public Health Genom. 2013;16:268-77.
6. Workshop on National Registries of RD. National Institute of Health. 2014.
7. Taruscio D, Vittozzi L, Choquet R, Heimdal K, Iskrov G, Kodra Y, et al. National registries of rare diseases in Europe: an overview of the current situation and experiences. Public Health Genomics. 2015;18:20-5.
8. Orphanet. Disease Registries in Europe. 2013.
9. Richesson RL, Sutphen R, Shereff D, Krischer JP. The rare diseases clinical research network contact registry update: features and functionality. Contemp Clin Trials. 2012;33:647-56.
10. Groft SC, Rubinstein YR. New and evolving rare diseases research programs at the National Institutes of Health. Public Health Genomics. 2013;16:259-67.
11. ® Common Data Elements: a leading force for standardized data collection. Contemp Clin Trials. 2015;42:78-80.
12. Villalobos J, Politei JM, Martins AM, Cabrera G, Amartino H, Lemay R, Ospina S, Ordoñez SS, Varas C. Fabry disease in latin America: data from the fabry registry. JIMD Rep. 2013;8:91-9.
13. Baldovino S, Moliner AM, Taruscio D, Daina E, Roccatello D. Rare diseases in Europe: from a wide to a local perspective. Isr Med Assoc J. 2016;18:359-63.
14. Stonebraker JS, Bolton-Maggs PHB, Soucie JM, Walker I, Brooker M. A study of variations in the reported haemophilia A prevalence around the world. Haemophilia. 2010;16:20-32.
15. Hemophilia WFo. Annual Global Survey. 2014.
16. Cortés Buelvas A. Hemofilia: terapéutica en las alteraciones hemostáticas. Colomb Med. 1999;30:10.
17. Capra R, Mattioli F, Kalman B, Marcianò N, Berenzi A, Benetti A. Two sisters with multiple sclerosis, lamellar ichthyosis, beta thalassaemia minor and a deficiency of factor VIII. J Neurol. 1993;240:336-8.
18. Ferreira AA, Leite ICG, Bustamante-Teixeira MT, Guerra MR. Hemophilia A in Brazil - epidemiology and treatment developments. J Blood Med. 2014;5:175-84.
19. Boldingh MI, Maniaol AH, Brunborg C, Dekker L, Heldal AT, Lipka AF, et al. Geographical distribution of myasthenia gravis in northern Europe-results from a population-based study from two countries. Neuroepidemiology. 2015;44:221-31.
20. Sánchez JL, Uribe CS, Franco AF, Jiménez ME, Arcos-Burgos OM, Palacio LG. [Prevalence of myasthenia gravis in Antioquia, Colombia]. Rev Neurol. 34:1010-2.
21. Mazzucato M, Visonà Dalla Pozza L, Manea S, Minichiello C, Facchin P. A population based registry as a source of health indicators for rare diseases: the 10-year experience of the Veneto Region's rare diseases registry. Orphanet J Rare Dis. 2014;9:37.
22. Walker CE, Mahede T, Davis G, Miller LJ, Girschik J, Brameld K, Sun W, Rath A, Aymé S, Zubrick SR, Baynam GS, Molster C, Dawkins HJS, Weeramanthri TS. The collective impact of rare diseases in Western Australia: an estimate using a population-based cohort. Genet Med. 2017;19:546-52.
23. Taruscio D, Arriola L, Baldi F, Barisic I, Bermejo-Sánchez E, Bianchi F, et al. European recommendations for primary prevention of congenital anomalies: a joined effort of EUROCAT and EUROPLAN projects to facilitate inclusion of this topic in the National Rare Disease Plans. Public Health Genom. 2014;17:115-23.
24. Aymé S, Bellet B, Rath A. Rare diseases in ICD11: making rare diseases visible in health information systems through appropriate coding. Orphanet J Rare Dis. 2015;10:35.